SANOCHEMIA CORPORATION USA

Serial Number 77421918
606

Registration Progress

Application Filed
Mar 14, 2008
Under Examination
Jan 20, 2009
Approved for Publication
Oct 8, 2008
Published for Opposition
Oct 28, 2008
Registered

Trademark Image

SANOCHEMIA CORPORATION USA

Basic Information

Serial Number
77421918
Filing Date
March 14, 2008
Published for Opposition
October 28, 2008
Abandonment Date
August 22, 2011
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 22, 2011
Classes
005

Rights Holder

Sanochemia Pharmazeutika AG

03
Address
Boltzmanngasse 9 a-11
Vienna A-1091
AT

Ownership History

Sanochemia Pharmazeutika AG

Original Applicant
03
Vienna AT

Sanochemia Pharmazeutika AG

Owner at Publication
03
Vienna AT

Legal Representation

Attorney
Cynthia J. Walden

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Aug 22, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 22, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 25, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 24, 2011 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 20, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 20, 2011 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 1, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2010 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 28, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2010 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 8, 2010 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 5, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2010 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 27, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 27, 2009 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 12, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 12, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 20, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 28, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 8, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Sep 19, 2008 ALIE A ASSIGNED TO LIE Loading...
Sep 19, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 11, 2008 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 11, 2008 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 11, 2008 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 11, 2008 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 11, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 18, 2008 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 18, 2008 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 18, 2008 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Aug 11, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 11, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 11, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 23, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 23, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 23, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 22, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 20, 2008 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Mar 19, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Test reagents for medical diagnosis; contrast media for use with X-ray, ultrasound and MRI medical and veterinary imaging; pharmaceutical products, namely, pharmaceutical preparations for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus, vasculitis, cancer, IBD, namely, ulcerative colitis and Crohn's disease, psoriasis, cutaneous lupus erythematosus, dermatitis, pemphigus, multiple sclerosis, demyelinating autoimmune diseases, Guillain-Barre syndrome neuromyelitis optica, myesthenia gravis, opthalmia, asthma, allergic rhinitis, hypersensitivity, anemia, diabetes mellitus, cardiovascular diseases, namely, angina pectoris, hypertension, myocardial infarction, CNS-disorders, namely, depression, schizophrenia, muscular spasm and pain, epilepsy
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of Stylization of "SANOCHEMIA" over "CORPORATION USA", all over heavy black line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CORPORATION" AND "USA"